E
TECX

Ergoteles’s Tectonic Therapeutic TECX Stock Holding History

Ergoteles’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,909
Closed -$33.4K – 1828
2022
Q4 		$33.4K Sell
3,909
-5,237
-57% -$46.1K ﹤0.01% 1326
2022
Q3 		$71K Sell
9,146
-2,441
-21% -$27.1K ﹤0.01% 1415
2022
Q2 		$128K Buy
+11,587
New +$137K ﹤0.01% 1456
2021
Q4 		– Sell
-1,735
Closed -$116K – 1653
2021
Q3 		$116K Buy
+1,735
New +$142K ﹤0.01% 1083

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ergoteles's TECX Position: Q1 2023 in Review

Ergoteles sold out of Tectonic Therapeutic (TECX) in Q1 2023, closing a stake of 3,909 shares — an estimated $33.4K sold.

Ergoteles first reported a position in TECX in Q3 2021 and held it in 4 quarters. The position peaked at $128K in Q2 2022. 48 funds tracked by Wall St. Rank hold TECX as of Q1 2023.

  • Ergoteles reported no remaining Tectonic Therapeutic position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 3,909 Tectonic Therapeutic shares in Q1 2023, an estimated $33.4K.
  • Ergoteles first reported a position in Tectonic Therapeutic in Q3 2021 and held it in 4 quarters.
  • Ergoteles's Tectonic Therapeutic position peaked at $128K in Q2 2022.
  • 48 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.